O-278 Randomized phase II study of cisplatin (P), irinotecan (I), and etoposide (E) combinations administered weekly or every four weeks for extensive small cell lung cancer (ESCLC): JCOG9902-DI
Saijo, Nagahiro, Sekine, Ikuo, Tamura, Tomohide, Nishiwaki, Yutaka, Noda, Kazumasa, Kudo, Shinzo, Fukuoka, Masahiro, Mori, Kiyoshi, Negoro, Syunichi, Yokoyama, Akira, Matsui, Kaoru, Osaki, Yoshinobu,Volume:
41
Langue:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)91936-2
Date:
August, 2003
Fichier:
PDF, 175 KB
english, 2003
File converter
Plus de résultats de recherche
More benefits 
